|
||
The Journal of General Physiology, Vol 101, 207-233, Copyright © 1993 by The Rockefeller University Press
ARTICLES |
L Xu, R Jones and G Meissner
Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill 27599-7260.
The effects of the two local anesthetics tetracaine and procaine and a quaternary amine derivative of lidocaine, QX314, on sarcoplasmic reticulum (SR) Ca2+ release have been examined by incorporating the purified rabbit skeletal muscle Ca2+ release channel complex into planar lipid bilayers. Recordings of potassium ion currents through single channels showed that Ca(2+)- and ATP-gated channel activity was reduced by the addition of the tertiary amines tetracaine and procaine to the cis (cytoplasmic side of SR membrane) or trans (SR lumenal) side of the bilayer. Channel open probability was lowered twofold at tetracaine and procaine concentrations of approximately 150 microM and 4 mM, respectively. Hill coefficients of 2.0 and greater indicated that the two drugs inhibited channel activity by binding to two or more cooperatively interacting sites. Unitary conductance of the K(+)- conducting channel was not changed by 1 mM tetracaine in the cis and trans chambers. In contrast, cis millimolar concentrations of the quaternary amine QX314 induced a fast blocking effect at positive holding potentials without an apparent change in channel open probability. A voltage-dependent block was observed at high concentrations (millimolar) of tetracaine, procaine, and QX314 in the presence of 2 microM ryanodine which induced the formation of a long open subconductance. Vesicle-45Ca2+ ion flux measurements also indicated an inhibition of the SR Ca2+ release channel by tetracaine and procaine. These results indicate that local anesthetics bind to two or more cooperatively interacting high-affinity regulatory sites of the Ca2+ release channel in or close to the SR membrane. Voltage-dependent blockade of the channel by QX314 in the absence of ryanodine, and by QX314, procaine and tetracaine in the presence of ryanodine, indicated one low-affinity site within the conduction pathway of the channel. Our results further suggest that tetracaine and procaine may primarily inhibit excitation-contraction coupling in skeletal muscle by binding to the high-affinity, regulatory sites of the SR Ca2+ release channel.
This article has been cited by other articles:
![]() |
P.-Y. von der Weid, M. Rahman, M. S. Imtiaz, and D. F. van Helden Spontaneous transient depolarizations in lymphatic vessels of the guinea pig mesentery: pharmacology and implication for spontaneous contractility Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H1989 - H2000. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Venetucci, A. W. Trafford, S. C. O'Neill, and D. A. Eisner The sarcoplasmic reticulum and arrhythmogenic calcium release Cardiovasc Res, January 15, 2008; 77(2): 285 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-a. Zhang, R. A. Tuft, L. M. Lifshitz, K. E. Fogarty, J. J. Singer, and H. Zou Caffeine-activated large-conductance plasma membrane cation channels in cardiac myocytes: characteristics and significance Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2448 - H2461. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pott and J. I. Goldhaber Is the Ryanodine Receptor a Target for Antiarrhythmic Therapy? Circ. Res., May 26, 2006; 98(10): 1232 - 1233. [Full Text] [PDF] |
||||
![]() |
S. Hollingworth, W. K. Chandler, and S. M. Baylor Effects of Tetracaine on Voltage-activated Calcium Sparks in Frog Intact Skeletal Muscle Fibers J. Gen. Physiol., February 27, 2006; 127(3): 291 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Xu, Y. Wang, D. Gillespie, and G. Meissner Two Rings of Negative Charges in the Cytosolic Vestibule of Type-1 Ryanodine Receptor Modulate Ion Fluxes Biophys. J., January 15, 2006; 90(2): 443 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Launikonis, J. Zhou, L. Royer, T. R. Shannon, G. Brum, and E. Rios Confocal imaging of [Ca2+] in cellular organelles by SEER, shifted excitation and emission ratioing of fluorescence J. Physiol., September 1, 2005; 567(2): 523 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, L. Xu, D. A. Pasek, D. Gillespie, and G. Meissner Probing the Role of Negatively Charged Amino Acid Residues in Ion Permeation of Skeletal Muscle Ryanodine Receptor Biophys. J., July 1, 2005; 89(1): 256 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Eisner, M. E. Diaz, Y. Li, S. C. O'Neill, and A. W. Trafford Stability and instability of regulation of intracellular calcium Exp Physiol, January 1, 2005; 90(1): 3 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Q. Wang, M. D. Stern, E. Rios, and H. Cheng The quantal nature of Ca2+ sparks and in situ operation of the ryanodine receptor array in cardiac cells PNAS, March 16, 2004; 101(11): 3979 - 3984. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Brum, N. Piriz, R. DeArmas, E. Rios, M. Stern, and G. Pizarro Differential Effects of Voltage-Dependent Inactivation and Local Anesthetics on Kinetic Phases of Ca2+ Release in Frog Skeletal Muscle Biophys. J., July 1, 2003; 85(1): 245 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.E. Diaz, D.A. Eisner, and S.C. O'Neill Depressed Ryanodine Receptor Activity Increases Variability and Duration of the Systolic Ca2+ Transient in Rat Ventricular Myocytes Circ. Res., October 4, 2002; 91(7): 585 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nishizawa, T. Shirasaki, S. Nakao, H. Matsuda, and K. Shingu The Inhibition of the N-Methyl-D-Aspartate Receptor Channel by Local Anesthetics in Mouse CA1 Pyramidal Neurons Anesth. Analg., February 1, 2002; 94(2): 325 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Overend, D. A. Eisner, and S. C. O'Neill Altered Cardiac Sarcoplasmic Reticulum Function of Intact Myocytes of Rat Ventricle During Metabolic Inhibition Circ. Res., February 2, 2001; 88(2): 181 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Eisner, H. S. Choi, M. E. Diaz, S. C. O'Neill, and A. W. Trafford Integrative Analysis of Calcium Cycling in Cardiac Muscle Circ. Res., December 8, 2000; 87(12): 1087 - 1094. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Hopkins Malignant hyperthermia: advances in clinical management and diagnosis Br. J. Anaesth., July 1, 2000; 85(1): 118 - 128. [Full Text] [PDF] |
||||
![]() |
M.E. Diaz, A.W. Trafford, S.C. O'Neill, and D.A. Eisner Can changes of ryanodine receptor expression affect cardiac contractility? Cardiovasc Res, March 1, 2000; 45(4): 1068 - 1069. [Full Text] [PDF] |
||||
![]() |
L. M. Sullivan, C. W. Honemann, J. A. Arledge, and M. E. Durieux Synergistic Inhibition of Lysophosphatidic Acid Signaling by Charged and Uncharged Local Anesthetics Anesth. Analg., May 1, 1999; 88(5): 1117 - 1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zucchi and S. Ronca-Testoni The Sarcoplasmic Reticulum Ca2+ Channel/Ryanodine Receptor: Modulation by Endogenous Effectors, Drugs and Disease States Pharmacol. Rev., March 1, 1997; 49(1): 1 - 52. [Abstract] [Full Text] [PDF] |
||||
|
|